Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis

P. W. Miller, A. Hamosh, M. Macek, P. A. Greenberger, J. MacLean, S. M. Walden, R. G. Slavin, G. R. Cutting*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

172 Scopus citations

Abstract

The etiology of allergic bronchopulmonary aspergillosis (ABPA) is not well understood. A clinical phenotype resembling the pulmonary disease seen in cystic fibrosis (CF) patients can occur in some individuals with ABPA. Reports of familial occurrence of ABPA and increased incidence in CF patients suggest a possible genetic basis for the disease. To test this possibility, the entire coding region of the cystic fibrosis transmembrane regulator (CFTR) gene was analyzed in 11 individuals who met strict criteria for the diagnosis of ABPA and had normal sweat electrolytes (≤40 mmol/liter). One patient carried two CF mutations (ΔF508/R347H), and five were found to carry one CF mutation (four ΔF508; one R117H). The frequency of the ΔF508 mutation in patients with ABPA was significantly higher than in 53 Caucasian patients with chronic bronchitis (P < .0003) and the general population (P < .003). These results suggest that CFTR plays an etiologic role in a subset of ABPA patients.

Original languageEnglish (US)
Pages (from-to)45-51
Number of pages7
JournalAmerican journal of human genetics
Volume59
Issue number1
StatePublished - 1996

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis'. Together they form a unique fingerprint.

Cite this